Kothari Payal, Mathur Aditi, Tirupathi Sunnypriyatham, Chauhan Rashmi, Nankar Meenakshi, Suvarna Ashrita
Department of Pediatric and Preventive Dentistry, Dr. D. Y. Patil Dental College & Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, Maharashtra, India.
Department of Pediatric Dentistry, PGICH, Noida, Uttar Pradesh, India.
Int J Clin Pediatr Dent. 2024 Jul;17(7):748-753. doi: 10.5005/jp-journals-10005-2871.
To evaluate and compare the clinical and radiographic success of NeoPUTTY® and Biodentine™ as indirect pulp treatment (IPT) materials in primary molars.
This clinical trial was conducted on children aged 5-9 years. Class I carious lesions in primary molars indicated for IPT were divided into two groups-group I, NeoPUTTY®, and group II, Biodentine™. IPC was performed as per the standard protocols. The treated teeth were evaluated for clinical and radiographic success, along with the presence of a dentinal bridge at 6 and 12 months, by three blind examiners independently. All the data were tabulated, and statistical analysis was performed using the Mann-Whitney test.
Interexaminer reliability was analyzed using Fleiss κ statistics, and it showed "good" agreement. Clinical success was 100% in both groups at 6- and 12-month follow-up, while radiographic success was also 100% at 6-month follow-up for both groups. However, at 12-month follow-up, it was 93.33% for group I and 100% for group II. The difference was statistically nonsignificant. The presence of a dentinal bridge at 12-month follow-up was seen in 86.66% of cases in group I and 100% of cases in group II, but there was no statistical difference observed between them with a -value of 0.555.
Within the limitations of the study, we conclude that NeoPUTTY® and Biodentine™ are equally effective as IPT agents in primary teeth.
Kothari P, Mathur A, Tirupathi S, Comparative Clinical and Radiographic Success Rate of Bioceramic Premix vs Biosilicate-based Medicament as Indirect Pulp Treatment Materials in Primary Molars: A Double-blind Randomized Trial with a Follow-up of 12 Months. Int J Clin Pediatr Dent 2024;17(7):748-753.
评估并比较NeoPUTTY®和Biodentine™作为乳牙间接盖髓治疗（IPT）材料的临床和影像学成功率。
本临床试验针对5至9岁儿童开展。将需进行IPT的乳牙I类龋损分为两组——第一组使用NeoPUTTY®，第二组使用Biodentine™。按照标准方案进行间接盖髓术。由三名盲法检查者独立评估治疗后的牙齿的临床和影像学成功率，以及在6个月和12个月时牙本质桥的存在情况。所有数据制成表格，并使用曼-惠特尼检验进行统计分析。
使用Fleiss κ统计分析检查者间的可靠性，结果显示一致性“良好”。在6个月和12个月的随访中，两组的临床成功率均为100%，而在6个月的随访中，两组的影像学成功率也均为100%。然而，在12个月的随访中，第一组为93.33%，第二组为100%。差异无统计学意义。在12个月的随访中，第一组86.66%的病例出现牙本质桥，第二组100%的病例出现牙本质桥，但二者之间无统计学差异，P值为0.555。
在本研究的局限性范围内，我们得出结论，NeoPUTTY®和Biodentine™作为乳牙IPT药物同样有效。
Kothari P, Mathur A, Tirupathi S, 乳牙间接盖髓治疗中生物陶瓷预混剂与生物硅酸盐类药物作为治疗材料的比较临床和影像学成功率：一项为期12个月随访的双盲随机试验。《国际临床儿科牙科学杂志》2024；17(7):748 - 753。
